MSA
CVS icon

McAlister Sweet & Associates’s CVS Health CVS Stock Holding History

McAlister Sweet & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,734
Closed -$1.79M – 25
2022
Q3 		$1.79M Buy
18,734
+1,032
+6% +$102K 1.91% 13
2022
Q2 		$1.64M Buy
+17,702
New +$1.73M 1.66% 21

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

McAlister Sweet & Associates's CVS Position: Q4 2022 in Review

McAlister Sweet & Associates sold out of CVS Health (CVS) in Q4 2022, closing a stake of 18,734 shares — an estimated $1.79M sold.

McAlister Sweet & Associates first reported a position in CVS in Q2 2022 and held it in 2 quarters. The position peaked at $1.79M in Q3 2022. 2,406 funds tracked by Wall St. Rank hold CVS as of Q4 2022.

  • McAlister Sweet & Associates reported no remaining CVS Health position as of Q4 2022 after selling out during the quarter.
  • McAlister Sweet & Associates sold 18,734 CVS Health shares in Q4 2022, an estimated $1.79M.
  • McAlister Sweet & Associates first reported a position in CVS Health in Q2 2022 and held it in 2 quarters.
  • McAlister Sweet & Associates's CVS Health position peaked at $1.79M in Q3 2022.
  • 2,406 funds tracked by Wall St. Rank held CVS Health as of Q4 2022.

Based on McAlister Sweet & Associates's 13F filing for Q4 2022, filed 10 Jan 2023.